| Reference | FOI 2025/1240 |
|---|---|
| Description | ADHD Assessments |
| Date Requested | 27/05/2025 |
| Date Replied | 10/06/2025 |
| Category | LDA Transformation |
1. I would like to know what the current situation for NHS ADHD adult assessments is.
1a. how long they have been paused for?
1b. when the plan is for them to start again?
1c. and how this information is passed on to GP practices.
2. I would also like to know on what grounds a GP can refuse a Shared Care agreement following a private diagnosis.
3. My understanding is that NICE states that there is an obligation to provide an assessment through the NHS, and if this is not available within the area, access should be provided via the private sector.
1a. Adult ADHD assessments have not been paused. There are long waiting lists in most areas, which may give rise to an understanding that they are not being completed currently.
1b. Please see response to question 1a
1c. Please see response to question 1a
2. Under the Greater Manchester Medicines Management Group (GMMMG) guidance, shared care agreements (SCAs) are collaborative arrangements between specialist services and general practitioners (GPs) to manage the prescribing and monitoring of medications, such as those used for Attention Deficit Hyperactivity Disorder (ADHD). These agreements are designed to ensure patient safety and continuity of care.
Grounds for GP Refusal of Shared Care Agreements Following an ADHD Diagnosis
GPs are not contractually obligated to enter into SCAs, especially following a private diagnosis. Several factors may influence a GP’s decision to decline such agreements:
a. Clinical Concerns: If the private assessment lacks comprehensive evaluation or does not align with established guidelines, GPs may question the validity of the diagnosis and the appropriateness of the prescribed medication. For instance, assessments that do not thoroughly exclude other conditions or lack detailed patient history may be deemed insufficient.
b. Continuity of Specialist Care: SCAs require ongoing involvement from the diagnosing specialist. If the private provider does not offer continued oversight or if there’s uncertainty about the patient’s ability to maintain private care, GPs may be reluctant to assume prescribing responsibilities.
c. Workload and Capacity: Given the increasing demands on primary care, GPs may decline SCAs due to limited resources or capacity to manage additional responsibilities, such as regular monitoring and follow-up appointments.
3. Access to NHS funded assessments has not been removed. Please see response to question 1a.